These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26210623)

  • 1. Long-term Outcomes in Youths with Diabetes Mellitus.
    White NH
    Pediatr Clin North Am; 2015 Aug; 62(4):889-909. PubMed ID: 26210623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic cardiovascular autonomic neuropathy: risk factors, clinical impact and early diagnosis.
    Rolim LC; Sá JR; Chacra AR; Dib SA
    Arq Bras Cardiol; 2008 Apr; 90(4):e24-31. PubMed ID: 18516377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and clinical aspects of cardiovascular vegetative neuropathy in a diabetic population].
    Fernández-Castañer M; Mendola G; Levy I; Gomis R; Figuerola D
    Med Clin (Barc); 1985 Feb; 84(6):215-8. PubMed ID: 3982131
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms and complications of adult diabetic patients in a family practice.
    Konen JC; Curtis LG; Summerson JH
    Arch Fam Med; 1996 Mar; 5(3):135-45. PubMed ID: 8620254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.
    Brownrigg JR; de Lusignan S; McGovern A; Hughes C; Thompson MM; Ray KK; Hinchliffe RJ
    Heart; 2014 Dec; 100(23):1837-43. PubMed ID: 25095826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathy in Diabetes: "One Cannot Begin It Too Soon".
    Pafili K; Papanas N; Ziegler D
    Angiology; 2018 Oct; 69(9):752-754. PubMed ID: 29334755
    [No Abstract]   [Full Text] [Related]  

  • 8. From diagnosis and classification to complications and therapy. DCCT. Part II? Diabetes Control and Complications Trial.
    Orchard TJ
    Diabetes Care; 1994 Apr; 17(4):326-38. PubMed ID: 8026291
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic neuropathy in children and youth: New and emerging risk factors.
    Akinci G; Savelieff MG; Gallagher G; Callaghan BC; Feldman EL
    Pediatr Diabetes; 2021 Mar; 22(2):132-147. PubMed ID: 33205601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Asymptomatic disorders of autonomic circulatory system regulation --frequent diabetes complications, but without prognostic significance in patients treated optimally].
    Narkiewicz K
    Kardiol Pol; 2009 Dec; 67(12):1333-4. PubMed ID: 20178149
    [No Abstract]   [Full Text] [Related]  

  • 12. The changing spectrum of type 2 diabetes mellitus.
    Kayima JK
    East Afr Med J; 2002 Aug; 79(8):397-8. PubMed ID: 12638838
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic strategy for diabetic polyneuropathy: Focus on nerve fiber type and magnetic resonance neurography.
    Sasaki H; Kishimoto S
    J Diabetes Investig; 2021 Feb; 12(2):140-142. PubMed ID: 32681709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.
    Wang SY; Andrews CA; Herman WH; Gardner TW; Stein JD
    Ophthalmology; 2017 Apr; 124(4):424-430. PubMed ID: 27914837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic complications of diabetes: a creative management approach.
    Eaks GA; Tiszka R
    Nurse Pract Forum; 1998 Jun; 9(2):74-86. PubMed ID: 9752122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in prevalence of cardiovascular risk factors from 2002 to 2012 among youth early in the course of type 1 and type 2 diabetes. The SEARCH for Diabetes in Youth Study.
    Kim G; Divers J; Fino NF; Dabelea D; Lawrence JM; Reynolds K; Bell RA; Mayer-Davis E; Crume T; Pettitt DJ; Pihoker C; Liu L
    Pediatr Diabetes; 2019 Sep; 20(6):693-701. PubMed ID: 30903717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular risk factors and diabetic neuropathy.
    Sone H; Mizuno S; Yamada N
    N Engl J Med; 2005 May; 352(18):1925-7; author reply 1925-7. PubMed ID: 15877321
    [No Abstract]   [Full Text] [Related]  

  • 19. [Professional recommendations for follow-up of the type 2 diabetic patient excluding the follow-up of complications. National Agency for the Accreditation and Evaluation of Health].
    J Mal Vasc; 1999 Jun; 24(3):239-44. PubMed ID: 10467537
    [No Abstract]   [Full Text] [Related]  

  • 20. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.